These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8400343)
1. Prognostic markers in cancers of the head and neck region. Kearsley JH; Thomas S Anticancer Drugs; 1993 Aug; 4(4):419-29. PubMed ID: 8400343 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma. Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome. de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240 [TBL] [Abstract][Full Text] [Related]
4. Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck? Jatana KR; Lang JC; Chalmers JJ Future Oncol; 2011 Apr; 7(4):481-4. PubMed ID: 21463135 [No Abstract] [Full Text] [Related]
5. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma. Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population. Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241 [TBL] [Abstract][Full Text] [Related]
7. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543 [TBL] [Abstract][Full Text] [Related]
8. Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer. Chen ZG Curr Cancer Drug Targets; 2007 Nov; 7(7):613-22. PubMed ID: 18045066 [TBL] [Abstract][Full Text] [Related]
9. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370 [TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression and its emerging role as a prognostic indicator in systemic tumors besides head and neck malignancies. Kapoor S J Surg Oncol; 2013 Mar; 107(4):446. PubMed ID: 22991299 [No Abstract] [Full Text] [Related]
11. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Bishop JA; Lewis JS; Rocco JW; Faquin WC Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476 [TBL] [Abstract][Full Text] [Related]
12. [Epidermal growth factor (EGF) receptors in squamous cell carcinoma of the head and neck region]. Lörz M; Bettinger R; Meyer-Breiting E Laryngorhinootologie; 1991 Aug; 70(8):438-40. PubMed ID: 1910383 [TBL] [Abstract][Full Text] [Related]
13. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma. Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392 [TBL] [Abstract][Full Text] [Related]
14. Pathobiology of head and neck squamous tumorigenesis. El-Naggar AK Curr Cancer Drug Targets; 2007 Nov; 7(7):606-12. PubMed ID: 18045065 [TBL] [Abstract][Full Text] [Related]
15. Biphenotypic human papillomavirus-associated head and neck squamous cell carcinoma: a report of two cases. Pitiyage G; Lei M; Guererro Urbano T; Odell E; Thavaraj S Diagn Pathol; 2015 Jul; 10():97. PubMed ID: 26169909 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Wallis SP; Stafford ND; Greenman J Head Neck; 2015 Mar; 37(3):449-59. PubMed ID: 24803283 [TBL] [Abstract][Full Text] [Related]
17. MCM2/TOP2A (ProExC) immunohistochemistry as a predictive marker in head and neck mucosal biopsies. Jenson EG; Baker M; Paydarfar JA; Gosselin BJ; Li Z; Black CC Pathol Res Pract; 2014 Jun; 210(6):346-50. PubMed ID: 24630889 [TBL] [Abstract][Full Text] [Related]
18. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Young MR; Wright MA; Lozano Y; Prechel MM; Benefield J; Leonetti JP; Collins SL; Petruzzelli GJ Int J Cancer; 1997 Feb; 74(1):69-74. PubMed ID: 9036872 [TBL] [Abstract][Full Text] [Related]
19. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437 [TBL] [Abstract][Full Text] [Related]
20. From epithelial dysplasia to squamous carcinoma of the head and neck region: evolutive and prognostic histopathological markers. Silvestri F; Bussani R; Pavletic N; Mannone T; Bosatra A Acta Otolaryngol Suppl; 1997; 527():49-51. PubMed ID: 9197481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]